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ABSTRACT
Background: Limited data are available examining dietary interventions for optimizing protein and leucine intake to stimulate muscle protein
synthesis (MPS) in older humans.
Objectives: We aimed to investigate the aminoacidemia and appetite responses of older adults after consuming breakfast, a meal frequently
consumed with high-carbohydrate and below-par amounts of protein and leucine for stimulating MPS.
Methods: Five men and 3 women (means ± SD; age: 74 ± 7 y, BMI: 25.7 ± 4.9 kg/m2, fat- and bone-free mass: 63 ± 7 kg) took part in this
experiment in which they consumed breakfasts with low-protein (LP = 13 ± 2 g), high-protein (HP = 32 ± 5 g), and LP followed by a protein- and
leucine-enriched bar formulation 2 h later (LP + Bar = 29 ± 2 g). The LP, HP, and LP + Bar breakfast conditions contained 519 ± 86 kcal,
535 ± 83 kcal, and 739 ± 86 kcal, respectively. Blood samples were drawn for 6 h and analyzed for amino acid, insulin, and glucose concentrations.
Visual analog scales were assessed for hunger, fullness, and desire to eat.
Results: The net AUC for essential amino acid (EAA) exposure was similar between the LP + Bar and HP conditions but greater in the HP condition
compared with the LP condition. Peak leucinemia was higher in the LP + Bar condition compared with the HP, and both were greater than the LP
condition. Net leucine exposure was similar between HP and LP + Bar, and both were greater than LP. Hunger was similarly reduced in LP + Bar
and HP, and LP + Bar resulted in a greater hunger reduction than LP. Both LP + Bar and HP resulted in greater net fullness scores than LP.
Conclusions: Consuming our bar formulation increased blood leucine availability and net exposure to EAAs to a similar degree as consuming a
high-protein meal. High-protein at breakfast results in a greater net exposure to EAAs and leucine, which could support MPS in older persons. This
study was registered at clinicaltrials.gov as NCT03712761. Curr Dev Nutr 2021;5:nzab080.
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Introduction
Aging is accompanied by a decline in skeletal muscle mass, increasing
the risk of physical disability (1, 2). A contributing factor to the loss of
muscle mass with aging is a diminished muscle anabolic response to a
given dose of protein, a phenomenon that has been termed anabolic re-
sistance (3). Anabolic resistance is characterized by a rightward shift in
the protein intake compared with muscle protein synthesis (MPS) dose–
response curve (4), such that higher protein intakes of 1.2–1.6 g pro-
tein/kg bodyweight/d are needed to maximally stimulate MPS (5). An
optimal per-meal protein dose has been suggested to be at least ∼0.4–
0.6 g/kg/meal (4).
Previous reports indicate that older adults often consume lower
quantities of protein at breakfast (6–10), which can result in a sub-
optimal quantity of protein to stimulate MPS. Practical limitations to
increase protein intake in older individuals at breakfast include age-
related anorexia, poor dentition, and the greater energy content of foods
to achieve such intakes (6, 7, 10, 11). An alternative strategy, rather than
recommending consuming more protein to stimulate MPS, would be
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FIGURE 1 Breakfast meals. (A) Lower-protein-containing breakfast and protein- and leucine-enriched bar (red circle). (B)
Higher-protein-containing breakfast without the bar.
stimulate MPS (12–15). Such a recommendation is concordant with an
increased leucine requirement in older persons (16).
Ingestion of protein and the subsequent hyperaminoacidemia is re-
quired to stimulate MPS in humans (17). Of all amino acids, leucine
is paramount for activating MPS (12, 13). Milk proteins have a high
leucine content (18), and coingestion of milk proteins with additional
free leucine would result in a rapid and sustained rise in circulating es-
sential amino acids (EAAs), particularly leucine. Hudson et al. (19) re-
ported that consuming 20 g whey protein 2 h after a 10-g low-protein
breakfast resulted in peak and composite postprandial aminoacidemia
comparable to consuming a single 30-g higher-protein breakfast.
Dietary protein has an enhanced acute postprandial effect on satiety
and fullness compared with carbohydrate and fat (20). Few studies have
TABLE 1 Nutritional profiles for each breakfast meal and bar1
LP HP Bar
Absolute values
Energy, kcal 519 ± 86 535 ± 83 220
Protein, g 13 ± 2 32 ± 5 16
CHO, g 87 ± 14 44 ± 10 22
Fat, g 17 ± 4 29 ± 7 11
Relative per BM, kg
Energy, kcal 7.7 ± 0.7 8.0 ± 0.6 3.4 ± 0.4
Protein, g 0.2 ± 0.0 0.5 ± 0.1 0.2 ± 0.0
CHO, g 1.3 ± 0.2 0.7 ± 0.1 0.3 ± 0.0
Fat, g 0.3 ± 0.0 0.4 ± 0.1 0.2 ± 0.0
Relative per LBM, kg
Energy, kcal 11.4 ± 1.0 11.8 ± 1.2 —
Protein, g 0.3 ± 0.0 0.7 ± 0.1 —
CHO, g 1.9 ± 0.2 1.0 ± 0.2 —
Fat, g 0.4 ± 0.1 0.7 ± 0.1 —
1Values are means ± SD. Participants (n = 8) received LP, HP, or LP followed by the
bar 2 h later in randomized order. BM, body mass; CHO, carbohydrate; HP, higher-
protein-containing breakfast; LBM, lean body mass; LP, lower-protein-containing
breakfast.
assessed the effects of oral leucine supplementation on satiety and full-
ness in humans (21, 22). The present study aimed to examine the effects
of ingesting a high-leucine-containing bar containing a micellar casein,
whey protein, and leucine blend on postprandial aminoacidemia and
subjective hunger, fullness, and desire to eat in older men and women.
We hypothesized that ingesting free leucine and a smaller amount of
protein (∼16 g) 2 h after a low-protein breakfast would result in post-
prandial plasma aminoacidemia over a 6-h postprandial period com-
parable to aminoacidemia observed after consuming a single higher-
protein-containing breakfast. Additionally, we hypothesized that ingest-
ing the bar would result in similar subjective ratings of hunger, fullness,




Five men and 3 women (mean ± SD age: 74 ± 7 y; BMI: 25.7 ± 4.9
kg/m2; body mass: 83 ± 17 kg; fat- and bone-free mass: 63 ± 7 kg; body
fat: 21 ± 8%) provided written consent after being informed of the pur-
pose, protocol, and risks of the study. Exclusion criteria were the regular
use of analgesic or anti-inflammatory drugs, history of neuromuscular
problems, musculoskeletal disease, any acute or chronic illness, tobacco
use or smoking, metabolic disorders, and the use of corticosteroids. The
Hamilton Integrated Research Ethics Board approved all experimental
procedures (project 3390). This study was registered at clinicaltrials.gov
as NCT03712761.
Experimental design
As previously described, this randomized crossover design study con-
sisted of 3 testing days ≥1 wk apart (23). Participants undertook 3 dif-
ferent conditions where they ingested low-protein breakfast (LP), high-
protein breakfast (HP), and low-protein breakfast followed by a protein-
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and leucine-enriched bar supplement consumed 2 h after breakfast
(LP + Bar). The evening before each visit, participants consumed a stan-
dardized dinner meal (5.5 ± 1.0 kcal/kg body mass), providing 19% of
energy as fat, 24% of energy as protein, and 57% of energy as carbo-
hydrate (Heart-to-Home Meals). On each testing day, participants re-
ported to the laboratory after an overnight fast. A venous catheter was
placed in the antecubital vein. Arterialized venous blood samples and
psychometric assessments of hunger and fullness were obtained before
(t = 0 min) and at 15, 30, 45, 60, 90, 120, 150, 180, 210, 240, 270, 300, and
360 min after breakfast ingestion, which was consumed within 15 min.
Study meals
Each participant consumed a breakfast meal designed to provide 25%
of their daily estimated energy needs to maintain energy balance, as de-
termined by the sex-specific Harris–Benedict equation using a mod-
erate physical activity factor. Meals were prepared the morning of the
trial with HP containing a combination of egg, processed meat slices,
cheese, yogurt, cookies/pastry, juice, fruit salad/fresh fruit, and LP con-
taining a combination of white bread with butter, cookies/pastry, juice,
fruit salad/fresh fruit (Figure 1). The total energy of the breakfast meal
consumed as protein was either 10% (LP) or 25% (HP) of the total en-
ergy content of the meal. The protein- and leucine-enriched bar (total
weight 57 g) contained ∼16 g of a blend of micellar casein (AMCO),
whey protein (Hilmar), whey protein hydrolysate (Hilmar), 1.5 g free
leucine (Ajinomoto), 22 g low-glycemic carbohydrates (Ciranda), and
11 g monounsaturated fat (Golden Barrel). The total leucine content of
the bar was ∼3.0 g, which has been shown to result in a stimulation of
MPS (13–15). The bars were made by Covance (Eurofins Food Integrity
and Innovation), and the nutrient content of the bar was estimated using
Product Solutions Research, Inc. The energy and macronutrient content
of all study meals and the bar can be found in Table 1.
Questionnaires
Validated questionnaires to assess hunger (“How hungry do you feel?”),
desire to eat (“How strong is your desire to eat?”), and fullness/satiety
(“How full do you feel?”) were completed throughout each of the visits
(24). Questions were randomly ordered at every time point, and all re-
sponses were assessed with a visual analog scale (VAS) incorporating a
100-mm horizontal line rating. Questions were neutrally worded, such
as “How full do you feel?”, with anchors of “Not at all” to “Extremely.”
Blood sample collection and analyses
Blood samples were collected and analyzed as previously described (23).
Although it was not possible to blind the participants or investigators,
all samples were analyzed and data collated in a blinded fashion until
statistical analysis was complete.
Statistical analyses
For amino acid concentrations and VAS scores, a 2-factor repeated-
measures ANOVA was used to identify the differences between treat-
ments and across time, as well as any treatment-by-time interaction.
Following a significant interaction, Fisher least significant difference
post hoc tests were conducted to isolate the pairwise differences. To de-
termine the differences between treatments in peak amino acid con-
centrations (Cmax), time to peak concentration (Tmax), and AUC, 1-
factor ANOVAs were used, and follow-up analyses included paired t-
































































FIGURE 2 Plasma leucine (A), branched-chain amino acid (BCAA;
B), and essential amino acid (EAA; C) concentrations (μM) in the
fasting state and after the ingestion of a lower-protein breakfast
containing 9–16 g protein (LP), higher-protein breakfast containing
23–40 g protein (HP), or a protein- and leucine-enriched bar
containing ∼16 g protein ingested 2 h after consuming LP
(LP + Bar) in healthy older men and women. Values are
means ± SEM, n = 8 per treatment. ∗LP significantly different from
HP (P < 0.05). †LP significantly different from LP + Bar (P < 0.05).
#HP significantly different from LP + Bar (P < 0.05).
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TABLE 2 Plasma amino acid, insulin, and glucose concentrations1
LP HP LP + Bar
Leucine
Cmax, μM 218 ± 61a 336 ± 78b 593 ± 176c
Tmax, min 116 ± 119a 180 ± 108a,b 221 ± 27b
AUC, μM/6 h 963 ± 280a 1556 ± 321b 1855 ± 455b
BCAA
Cmax, μM 800 ± 246a 1217 ± 270b 1305 ± 342b
Tmax, min 216 ± 124 229 ± 109 229 ± 27
AUC, μM/6 h 3528 ± 1060a 5506 ± 1013b 4925 ± 947b
EAA
Cmax, μM 2176 ± 827 3684 ± 2217 3567 ± 1940
Tmax, min 167 ± 110 148 ± 67 161 ± 94
AUC, μM/6 h 9611 ± 3065a 14,953 ± 6241b 13,854 ± 6076a,b
Insulin
Cmax, mU/L 62 ± 8a 50 ± 5b 75 ± 4c
Tmax, min 75 ± 28a 62 ± 19a,b 43 ± 5b
AUC, mU/L/6 h 168 ± 10a 149 ± 5 b 190 ± 14c
Glucose
Cmax, mmol/L 7 ± 0 7 ± 1 7 ± 1
Tmax, min 24 ± 8 21 ± 8 23 ± 11
AUC, mmol/L/6 h 31 ± 1 31 ± 1 31 ± 1
1Values are means ± SD, n = 8 per treatment. Treatments without a common letter differ, P < 0.05. BCAA, branched-chain
amino acid; Cmax, peak concentration; EAA, essential amino acid; HP, higher-protein-containing breakfast; LP, lower-protein-
containing breakfast; LP + Bar, protein- and leucine-enriched bar ingested 2 h after consuming LP; Tmax, time to reach peak
concentration.
tests (IBM SPSS Statistics, v.25). The net AUC (subtract the area un-
der baseline) data presented were analyzed by 1-factor ANOVA and
Tukey post hoc tests for the different treatments (GraphPad Prism,
Inc. Version 7.0). The significance level was set at α ≤ 0.05 for all
comparisons.
Results
Plasma amino acid, insulin, and glucose concentrations
Amino acid concentrations increased after meal ingestion (Figure 2).
Leucine, branched-chain amino acid (BCAA), and essential amino
acid (EAA) concentrations increased to a greater extent after HP and
LP + Bar compared with LP (time-by-treatment: P < 0.003; Figure 2A–
C). LP + Bar resulted in greater increases in leucine, BCAA, and EAA
concentrations when compared with LP.
Peak leucine concentrations were higher after LP + Bar when com-
pared with LP and HP, and higher after HP when compared with
LP (P < 0.05; Table 2). Peak BCAA concentrations were higher after
LP + Bar and HP when compared with LP (P < 0.05). The leucine
and BCAA AUCs over the entire 6-h postprandial period were higher
after LP + Bar and HP compared with LP (P < 0.05), with no differ-
ence between HP and LP + Bar. The AUC for EAA concentrations was
higher after HP when compared with LP (P < 0.05). For LP + Bar,
the EAA AUC did not differ from both HP and LP (P > 0.05). Peak
insulin concentrations were higher after LP + Bar when compared
with LP and HP (P < 0.05). For HP, insulin concentrations were lower
than LP (P < 0.05; Table 2). The AUC of insulin concentrations fol-
lowed the same trend (Table 2). There were no significant differences
in glucose concentrations among groups throughout the postprandial
period.
Subjective ratings of desire to eat, fullness, and hunger
The perceived desire to eat and hunger transiently decreased after meal
ingestion (time-by-treatment: P < 0.041; Figure 3A, B), and more
rapidly returned to baseline values after LP compared with HP. After
consuming the LP + Bar, desire to eat and hunger remained lowered,
which is likely due to the caloric content of the bar. The AUC over the
entire 6-h postprandial period for hunger was lower after LP + Bar
when compared with LP (P = 0.038, Figure 3B, E). The AUC of per-
ceived fullness was higher for both HP and LP + Bar when compared
with LP (P = 0.033; Figure 3F).
Discussion
We observed that the consumption of a high-leucine-containing protein
bar containing approximately half the energy of the LP meal 2 h after
an LP breakfast resulted in a greater hyperaminoacidemia (particularly
leucinemia) and attenuated postprandial ratings of the desire to eat and
hunger, and increased ratings of fullness. In agreement with our hypoth-
esis, EAA concentrations throughout the postprandial period and sub-
jective appetite sensations did not differ between LP + Bar and HP, and
peak leucine concentrations were highest following bar ingestion. The
present study demonstrated that a protein- and leucine-enriched bar
ingested 2 h after a lower-protein-containing breakfast resulted in peak
leucinemia greater than after consuming a higher-protein-containing
breakfast (Table 2). Our findings (peak plasma leucine ∼590 μM) are
consistent with a previous study that showed peak leucine concentra-
tions of ∼500 μM after ingesting a 20-g whey protein beverage (∼3 g
leucine) (19). In comparison, a 10-g protein breakfast and 30-g protein
breakfast elicited lower peak leucinemia (∼145 μM and ∼245 μM, re-
spectively) in young males and females (19). The present study utilized
a similar experimental protocol and testing procedures as Hudson et al.
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FIGURE 3 The effects of a protein-and leucine-enriched bar on the desire to eat (A and D), hunger (B and E), and fullness (C and F) [mm
and mm·360 min−1(6 h)] in the fasting state and after the ingestion of a lower-protein breakfast containing 9–16 g protein (LP), a
higher-protein breakfast containing 23–40 g protein (HP), or a protein- and leucine-enriched bar containing ∼16 g protein and 220 kcal
ingested 2 h after consuming LP (LP + Bar) in healthy older men and women. VAS values are means (error bars on VAS scores are omitted
for clarity), n = 8 per treatment. Net AUC values are presented as box-and-whisker plots with the whiskers showing maximum and
minimum values, the box the IQR, the cross (+) shows the mean, and the line is the median. ∗Significantly different from LP (P < 0.05).
VAS, visual analog scale.
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(19), with the exception that we included older men and women and
that we tested the effects of a breakfast bar containing ∼16 g protein
with ∼1.5 g free leucine (as opposed to a 20-g whey protein beverage).
Ingestion of protein that results in a rapid leucinemia, along with
a sustained supply of EAAs, stimulates and maintains MPS (12, 13,
25, 26). Previous studies showed that low protein intakes (e.g., ∼10 g)
in a mixed meal or as isolated proteins do not robustly increase
aminoacidemia or MPS in older persons (27, 28). For older adults, who
typically consume less protein at the morning meal (6–10), modulating
their eating patterns to increase plasma leucinemia and EAA concentra-
tions can stimulate MPS. Our previous data demonstrated that blood
leucine concentrations of ∼450 μM resulted in increased integrated
MPS rates over 3 d in older males consuming low- or high-protein-
containing diets (29), and the same was true for older women (12, 13).
In the present study, we found that a leucine-enriched bar containing
∼16 g protein and 1.5 g free leucine resulted in peak leucinemia of ∼590
μM and maintained plasma EAA concentrations. The ingestion of the
bar also resulted in similar net EAA and higher BCAA exposure than
the higher-protein diet in our previous study (29), as indicated by the
AUC (Table 2). The bar was formulated to take advantage of differing
digestion and absorption kinetics (milk proteins being slower to digest
and absorb than free leucine) and provide high concentrations of EAAs,
BCAAs, and leucine, which can better elicit an initial rapid followed by
a sustained hyperaminoacidemia.
The postprandial leucinemia after bar ingestion was similar to that
previously reported as being sufficient to stimulate MPS following the
ingestion of a single dose of leucine-enriched EAAs in young and older
adults (30), a suboptimal dose of whey protein enriched with leucine in
young men (14, 15), and beverages containing either 20 or 40 g whey
protein in older men (27) and women (12, 13). The peak leucinemia re-
ported in older men and women in the present study was also higher
than those reported in a previous study in younger women (21). In
an acute feeding study on a protein- and leucine-enriched bar con-
taining 13 g milk protein and 3.0 g additional leucine, the magnitude
of the increase in peak leucinemia (Cmax) was ∼40% lower compared
with the results of the present study (∼420 μM compared with ∼590
μM) (21). In the present study, peak leucinemia exceeded the plasma
leucine response previously reported after consuming a 40-g whey pro-
tein beverage (∼320 μM) (27). The rate of dietary protein digestion
and amino acid absorption and the subsequent availability of dietary
protein–derived amino acids in circulation depend on gastric and in-
testinal motility, luminal digestion, and mucosal absorption (31–33).
Thus, the postprandial leucine availability was adequate using a bar de-
livery system that utilized lower protein amounts in older adults. Fu-
ture studies should examine the present protein- and leucine-enriched
bar formulation with muscle biopsies to determine if the bar enhances
MPS directly when used during a resistance training program.
To our knowledge, no previous studies have examined the effects of
breakfast meals and acute ingestion of protein-containing bars on sub-
jective appetite sensations in older adults (Figure 3). In agreement with
our results, Bolster et al. (21) reported that lower-protein-containing
nutrition bars coingested with 2 g or 3 g leucine peptides increased post-
prandial fullness ratings. Ingestion of 2 g leucine peptides decreased
hunger and desire to eat in younger women. Coingesting 3 g leucine
peptides did not further stimulate satiety, probably because leucine
transporters likely reached a saturation point (21). However, there is
limited information regarding the role of plasma leucinemia in the reg-
ulation of appetite following consumption of a suboptimal protein dose
containing fast and slow digestible proteins, free leucine, low glycemic
index carbohydrates, and monounsaturated fat in humans (20). We
achieved plasma leucine concentrations higher than after the high-
protein breakfast using the protein- and leucine-enriched bar. We ac-
knowledge that our study design resulted in an increased energy and
carbohydrate intake in the LP + Bar condition due to the bar’s ingestion
compared with the LP and HP conditions. However, after the bar inges-
tion at 120 min, we observed no further increases (Tmax = 43 ± 5 min) in
plasma insulin concentrations; instead, plasma insulin concentrations
decreased (data not reported). This result was likely due to the bar’s
sweetener system, also containing low-glycemic carbohydrates, which
do not cause a rapid increase in postprandial blood glucose (34). Higher
carbohydrate intake might not be desirable for older individuals at risk
of developing diabetes, and therefore dietary strategies should also aim
at reducing carbohydrate intake. The impact of the greater energy in-
take, if that is what is sensed in appetite, cannot be discounted in the
LP + Bar condition. We elected to study a protein- and leucine-enriched
bar as a postbreakfast snack, which does not induce hyperglycemia, to
more closely mimic how the bar’s ingestion would affect older persons
who commonly consume a lower-protein-containing breakfast.
In conclusion, consuming a protein bar containing ∼16 g milk pro-
teins blended with 1.5 g free leucine and half the LP breakfast meal’s
energy content 2 h after a lower-protein, wholefood breakfast increased
leucinemia and promoted satiety. Our findings and those from previ-
ous studies provide a rationale for future research in clinical settings
designed to improve muscle anabolism while potentially regulating ap-
petite.
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